This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia

Phase 3 Completed 357 enrolled Viatris Inc.

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081100 and who wish to receive open-label pregabalin therapy.

Timeline

Start: 2006-12
Primary completion: 2008-02
Completion: 2008-02

Publications

Arnold LM, Emir B, Murphy TK, Zeiher BG, Pauer L, Scott G, Petersel D. Safety profile and tolerability of up to 1 year of pregabalin treatment in 3 open-label extension studies in patients with fibromyalgia. Clin Ther. 2012 May;34(5):1092-102. doi: 10.1016/j.clinthera.2012.03.003. Epub 2012 Apr 14.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	150 mg	—
Subject	Pregabalin	Small molecule	600 mg	—

This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia

Summary

Timeline

Publications

Drugs

Indications